Keywords: AHA Scientific Statements; LDL cholesterol; antihypertensive agents; aspirin; atherosclerosis; atherosclerotic cardiovascular disease; atrial fibrillation; behavior modification; behavior therapy; blood cholesterol; blood pressure; body mass index; cardiovascular; cardiovascular disease; cardiovascular team-based care; cholesterol; chronic kidney disease; coronary artery calcium score; coronary disease; coronary heart disease; cost; diabetes mellitus; diet; dietary fats; dietary patterns; dietary sodium; dyslipidemia; e-cigarettes; exercise; guidelines; health services accessibility; healthcare disparities; heart failure; hypertension; lifestyle; lipids; measurement; myocardial infarction; nicotine; nonpharmacological treatment; nutrition; physical activity; prejudice; primary prevention; psychosocial deprivation; public health; quality indicators; quality measurement; risk assessment; risk factors; risk reduction; risk reduction discussion; risk treatment discussion; risk-enhancing factors; secondhand smoke; sleep; smoking; smoking cessation; social determinants of health; socioeconomic factors; statin therapy; systems of care; tobacco; tobacco smoke pollution; treatment adherence; treatment outcomes; type 2 diabetes mellitus; waist circumference; weight loss.